J&J seals $2.1bn deal on sale of major diabetes devices firmAs part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson & Share XJ&J seals $2.1bn deal on sale of major diabetes devices firmhttps://pharmaphorum.com/news/jj-deal-glucose-monitoring-system/